Commercial excellence and AI - a ripple, wave or a tsunami

AI is rapidly reshaping Commercial Excellence in life sciences, but the scale of its impact remains an open question. Will AI create a ripple by improving productivity, a wave by transforming how insights are generated and decisions are made, or a tsunami that fundamentally redefines Commercial Excellence operating models? As organizations move beyond experimentation, commercial leaders are evaluating where AI can create meaningful value, how it can be embedded into decision-making, and what role human judgment will continue to play.

Join Amit Grover, AVP of Commercial Excellence at Stemline Therapeutics, Nikhil Tolani, Manager - Platform Services at ZS and Nakul Korde, Principal at ZS for a candid discussion on the future of AI-powered Commercial Excellence, including how platforms such as ZAIDYN® help connect commercial data, intelligence, AI and workflows to move organizations from insight generation to intelligent action.

You'll discover:

How Commercial Excellence is evolving from reporting and analytics to continuous decision intelligence
Where AI is delivering measurable impact today and how agentic intelligence is reshaping commercial decision-making and execution
Why trusted data, commercial context, governance and human judgment remain critical in an AI-first world
How platforms such as ZAIDYN® help connect commercial data, intelligence, AI and workflows to accelerate enterprise adoption and business impact

Whether you're evaluating your AI strategy, modernizing Commercial Excellence capabilities or preparing for the next generation of commercial operating models, this session will provide practical perspectives on what lies ahead and how organizations can prepare for the ripple, wave—or tsunami—of AI-driven transformation.

Amit Grover

AVP, Commercial Excellence

Stemline Therapeutics

Amit Grover is an accomplished biopharma leader with over 22 years of experience in sales and marketing analytics (including 14+ years of commercial launch excellence in Hematology/Oncology/rare disease), AI-driven advanced analytics, and market development. As AVP of Commercial Excellence at Stemline Therapeutics, Amit architected cross-functional data infrastructure and optimized commercial analytics and operations for key brands like Orserdu and Elzonris. With a strong track record spanning strategic leadership position at Pharmacyclics and Nektar Therapeutics, he earned top honors including the President's Club and Pinnacle awards.

Nakul Korde

Principal

Nakul Korde is a Principal at ZS and a leader within the firm's mid-cap and emerging biopharma practice. With more than 17 years of experience in oncology and rare diseases, he advises life sciences organizations on technology-enabled transformation, helping them improve operational effectiveness, strengthen governance, and accelerate business impact through strategic advisory and digital innovation.

Nikhil Tolani

Manager, Platform Services

Nikhil Tolani is a leader at ZS with more than 12 years of experience in life sciences and deep expertise in commercial data, analytics, and technology. He partners with life sciences organizations to build and scale commercial capabilities, leading complex transformations that connect data, technology, and business strategy. His current focus is bringing AI and agentic capabilities into Commercial Excellence, helping commercial teams access insights, make decisions, and take action faster, accelerating the journey from insight to impact.

Country

Commercial excellence and AI - a ripple, wave or a tsunami

Panelists

Moderator

Register for the webinar